Treatment Overview
Transurethral Resection of the Prostate (TURP) for patients with cardiovascular risk is a minimally invasive procedure designed to treat benign prostatic hyperplasia (BPH) while minimizing the potential stress on the heart and blood vessels. Patients with conditions such as hypertension, coronary artery disease, arrhythmias, or previous cardiac events require special perioperative care.
In Korea, TURP for cardiovascular-risk patients is performed in state-of-the-art urology centers using monopolar, bipolar, or laser technologies with high-definition endoscopic visualization. Surgeons and anesthesiologists collaborate closely to ensure patient safety and effective relief of urinary obstruction.
Purpose & Benefits
The primary purpose of TURP for cardiovascular-risk patients is to relieve lower urinary tract symptoms (LUTS) caused by BPH while reducing anesthesia- and surgery-related cardiac stress.
Key benefits include:
- Effective relief of urinary obstruction and LUTS
- Minimally invasive with lower cardiac stress compared to open surgery
- Customizable anesthesia options (spinal or carefully monitored general anesthesia)
- High precision tissue removal with monopolar, bipolar, or laser technology
- Shorter hospital stay and faster recovery
- Reduced risk of perioperative cardiovascular complications
This procedure is particularly suitable for patients with known cardiovascular conditions who require safe BPH treatment.
Ideal Candidates
Ideal candidates include:
- Men with moderate to severe LUTS due to BPH
- Patients with cardiovascular conditions such as hypertension, coronary artery disease, or arrhythmias
- Individuals on anticoagulant or antiplatelet therapy
- Patients with prior cardiac events or high perioperative risk
- Those seeking minimally invasive surgery with careful cardiovascular monitoring
Eligibility is determined after comprehensive evaluation, including cardiology consultation, imaging, and urology assessment.
Possible Risks & Complications
TURP for patients with cardiovascular risk is generally safe with proper monitoring, but potential risks include:
- Temporary hematuria (blood in urine)
- Mild urinary urgency or discomfort
- Urinary tract infection
- Temporary urinary incontinence
- Urethral stricture or bladder perforation (rare)
- Anesthesia-related cardiovascular complications such as blood pressure fluctuations or arrhythmias
- Rare TUR syndrome (mainly in monopolar TURP)
Korean hospitals reduce risks with careful preoperative assessment, real-time monitoring, and skilled surgical and anesthesia teams.
Techniques & Technology Used
Korean hospitals employ advanced techniques for TURP in cardiovascular-risk patients:
- Monopolar, bipolar, or laser TURP depending on patient and prostate size
- High-definition endoscopic cameras for precise visualization
- Continuous irrigation for clear surgical field
- Advanced electrosurgical or laser units with precise energy control
- Customized anesthesia protocols and perioperative cardiovascular monitoring
- Postoperative catheterization and bladder irrigation protocols
This ensures safe, effective surgery with minimal cardiac stress.
Treatment Process in Korea
The treatment process begins with preoperative evaluation including urinalysis, imaging, laboratory tests, and cardiology consultation. TURP is performed under spinal or general anesthesia tailored to minimize cardiovascular risk.
A resectoscope is inserted through the urethra to remove excess prostate tissue. Catheterization is typically required for 1–2 days postoperatively, and hospital stay generally ranges from 1–3 days depending on patient condition and surgical approach.
International patient services assist with scheduling, translation, and follow-up care.
Recovery & After-Care
Recovery for cardiovascular-risk patients includes:
- Close monitoring of urinary output, infection, and cardiovascular status
- Catheter removal usually within 1–2 days
- Mild urinary discomfort or temporary burning may occur
- Avoid heavy lifting or strenuous activity initially
- Maintain hydration, follow prescribed medications, and monitor cardiovascular health
- Follow-up appointments to ensure proper healing and symptom improvement
Remote follow-up is often available for international patients.
Results & Longevity
TURP for cardiovascular-risk patients provides durable relief of urinary obstruction and LUTS, with most patients experiencing improved urinary flow and quality of life. Adherence to postoperative care and ongoing cardiac monitoring supports long-term outcomes.
Why Korea Is a Top Destination
Korea is a leading destination for TURP for cardiovascular-risk patients due to:
- Highly skilled urologists experienced in managing high-risk patients
- Advanced endoscopic and laser technologies
- Specialized anesthesia and perioperative care for cardiovascular safety
- High clinical success rates with minimal complications
- Short hospital stays and efficient recovery
- Comprehensive support for international medical tourists
These factors make Korea ideal for patients with cardiovascular risk seeking safe and effective BPH treatment.
Cost Range
The cost of TURP for cardiovascular-risk patients in Korea typically ranges from USD 5,000 to USD 10,000. Costs vary depending on hospital type, surgeon expertise, anesthesia, prostate size, and technology used.
Korean hospitals offer competitive pricing while providing high-quality care for high-risk patients.
Popular Clinics in Korea
Reputable hospitals offering TURP for cardiovascular-risk patients include:
- University-affiliated tertiary hospitals
- Specialized urology and BPH centers
- International patient-focused hospitals in Seoul and Gangnam
- Multispecialty hospitals with advanced endourology units
Clinic selection should prioritize surgeon expertise, anesthesia protocols, and patient support services for high-risk individuals.
